Lysine: Clinical Trials

15 trials of Lysine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 2 recruiting, 1 unknown. 10 Not applicable, 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 10
Phase 14Completed 2, Recruiting 1, Unknown 1
Phase 22Recruiting 2

Follow Lysine: new trials by email Literature Review of Lysine trials Research Report on Lysine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
Actinium Ac 225 DOTATATE RYZ101, Biospecimen Collection, Computed Tomography - Recurrent Meningioma
Phase 1 / Phase 2RecruitingJoshua Palmer302025-11-122026-08-13
Leucine in Midlife Depression
L-leucine, L-lysine - Major Depression
Phase 2RecruitingEmory University752025-02-012026-09-11
Effect of Lysine and Phosphorus Fortification on Glycemic Index and Postprandial Glycemia in Double Fortified Bread
Control Group - Standard White Bread, Lysine Group - Lysine-Fortified Bread, Phosphorus Group - Phosphorus-Fortified Bread - Hyperglycemia, Glucose Metabolism Disorders
Not applicableCompletedUniversity of Veterinary and Animal Sciences, Lahore - Pakistan162023-11-132024-11-12
Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3
L-Lysine, Normal Saline - Diabetes Mellitus, Type 2
Phase 1CompletedVanderbilt University Medical Center232022-03-092024-06-05
Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2
Lysine, Controlled Diet - Healthy
Not applicableCompletedVanderbilt University Medical Center672020-08-172023-12-21
The Effect of Bread Fortification With Phosphorus and Lysine on Postprandial Glycaemia and Thermogenesis
lysine and phosphorus - Postprandial Hyperglycemia, Energy Expenditure
Not applicableCompletedAmerican University of Beirut Medical Center162019-02-062025-10-06
Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors
177Lu-DOTA-EB-TATE 1, 177Lu-DOTA-TATE, 177Lu-DOTA-EB-TATE 2 - Neuroendocrine Tumors
Phase 1UnknownPeking Union Medical College Hospital602017-04-302022-08-31
The Effect of Acute Lysine Administration on α-aminoadipic Acid
L-Lysine, Normal (0.9%) Saline - Healthy, Pre-diabetic
Phase 1CompletedVanderbilt University132016-05-012017-02-07
Randomized Controlled Trial in South Africa Comparing the Efficacy of Complementary Food Products on Child Growth
Fortified fat-based paste with essential fatty acids, DHA, ARA, phytase, L-lysine, potassium, phosphorous, magnesium and manganese, Fortified fat-based paste with essential fatty acids - Malnutrition
Not applicableCompletedNorth-West University, South Africa7502013-09-012017-11-30
The Effect of L-lysine on Human Gastrointestinal Secretion: A Dose-finding Study Applying Magnetic Resonance Imaging (MRI)
L-lysine - Healthy
Not applicableCompletedUniversity of Zurich62012-04-012015-05-28
Effects of L-lysine on Adrenal Secretion
L-lysine, placebo - Male, Healthy Volunteers
Not applicableCompletedUniversity Hospital, Rouen202010-10-012026-04-16
L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer
quality-of-life assessment, management of therapy complications, L-lysine - Mucositis, Oral Complications of Chemotherapy
Not applicableCompletedUniversity of Washington102010-09-012013-05-17
Estrogen and Serotonin on Changing Brain Chemistry
estrogen patch, Amino acids, Placebo Patch - Menopause
Not applicableCompletedUniversity of Colorado, Denver472010-03-042021-04-02
Muscle Regrowth During Physical Rehabilitation and Amino Acid Supplementation
Essential amino acids, Alanine - Osteoarthritis
Not applicableCompletedUniversity of Oregon602008-06-012014-12-04
An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia
L-lysine - Schizophrenia
Not applicableCompletedGöteborg University102007-09-012009-10-16

Conditions studied

Hyperglycemia (2)  ·  Depressive Disorder, Major (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Glucose Intolerance (1)  ·  Glucose Metabolism Disorders (1)  ·  Inflammation (1)  ·  Malnutrition (1)  ·  Memory Disorders (1)  ·  Meningioma (1)  ·  Metabolic Diseases (1)  ·  Mucositis (1)  ·  Neuroendocrine Tumors (1)  ·  Osteoarthritis (1)  ·  Salivary Gland Neoplasms (1)  ·  Schizophrenia (1)

Sponsors

Vanderbilt University Medical Center (2)  ·  American University of Beirut Medical Center (1)  ·  Emory University (1)  ·  Göteborg University (1)  ·  Joshua Palmer (1)  ·  North-West University, South Africa (1)  ·  Peking Union Medical College Hospital (1)  ·  University Hospital, Rouen (1)  ·  University of Colorado, Denver (1)  ·  University of Oregon (1)  ·  University of Veterinary and Animal Sciences, Lahore - Pakistan (1)  ·  University of Washington (1)  ·  University of Zurich (1)  ·  Vanderbilt University (1)

Countries

United States (7)  ·  China (1)  ·  France (1)  ·  Lebanon (1)  ·  Pakistan (1)  ·  South Africa (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Cornelius M Smuts, PhD (1)  ·  Cynthia Neill Epperson, M.D. (1)  ·  Ebrahim Haroon, MD (1)  ·  Hans C Dreyer, PT, PhD (1)  ·  Jane F Ferguson, PhD (1)  ·  Jane Ferguson, PhD (1)  ·  Joshua D Palmer, MD (1)  ·  Mah Noor, MPhil (1)  ·  Omar Obeid, PhD (1)  ·  Upendra Parvathaneni (1)  ·  Werner Schwizer, Prof. MD (1)  ·  Zhaohui Zhu, M.D.,PhD (1)

Results publications

PMID 19553295, PMID 21501494, PMID 22204954, PMID 24135139, PMID 25100072, PMID 26514124, PMID 27269925, PMID 28103616, PMID 30649163, PMID 30965074, PMID 31832728, PMID 36132073, PMID 37075254

NIH funding

K01HD057332 (1), P50MH099910 (1), R01DK117144 (1), R01MH132059 (1)